Cargando…

Turning Microbial AhR Agonists into Therapeutic Agents via Drug Delivery Systems

Developing therapeutics for inflammatory diseases is challenging due to physiological mucosal barriers, systemic side effects, and the local microbiota. In the search for novel methods to overcome some of these problems, drug delivery systems that improve tissue-targeted drug delivery and modulate t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puccetti, Matteo, Pariano, Marilena, Wojtylo, Paulina, Schoubben, Aurélie, Giovagnoli, Stefano, Ricci, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966334/ https://www.ncbi.nlm.nih.gov/pubmed/36839828 http://dx.doi.org/10.3390/pharmaceutics15020506

Ejemplares similares

Pharmaceutically Active Microbial AhR Agonists as Innovative Biodrugs in Inflammation
por: Puccetti, Matteo, et al.
Publicado: (2022)

Biodrug Delivery Systems: Do mRNA Lipid Nanoparticles Come of Age?
por: Puccetti, Matteo, et al.
Publicado: (2023)

Tryptophan as a Central Hub for Host/Microbial Symbiosis
por: Borghi, Monica, et al.
Publicado: (2020)

The Coevolution of IDO1 and AhR in the Emergence of Regulatory T-Cells in Mammals
por: Grohmann, Ursula, et al.
Publicado: (2015)

Tryptophan Supplementation Increases the Production of Microbial-Derived AhR Agonists in an In Vitro Simulator of Intestinal Microbial Ecosystem
por: Koper, Jonna EB, et al.
Publicado: (2022)

The Landscape of AhR Regulators and Coregulators to Fine-Tune AhR Functions
por: Gargaro, Marco, et al.
Publicado: (2021)

Targeted Drug Delivery Technologies Potentiate the Overall Therapeutic Efficacy of an Indole Derivative in a Mouse Cystic Fibrosis Setting
por: Puccetti, Matteo, et al.
Publicado: (2021)

Ketorolac Loaded Poly(lactic-co-glycolic acid) Coating of AZ31 in the Treatment of Bone Fracture Pain
por: Puccetti, Matteo, et al.
Publicado: (2023)

The Highly Potent AhR Agonist Picoberin Modulates Hh-Dependent Osteoblast Differentiation
por: Flegel, Jana, et al.
Publicado: (2022)

Tumor-Suppressive Functions of the Aryl Hydrocarbon Receptor (AhR) and AhR as a Therapeutic Target in Cancer
por: Elson, Daniel J., et al.
Publicado: (2023)

Tryptophan Feeding of the IDO1-AhR Axis in Host–Microbial Symbiosis
por: Zelante, Teresa, et al.
Publicado: (2014)

Serotonin Modulates AhR Activation by Interfering with CYP1A1-Mediated Clearance of AhR Ligands
por: Manzella, Christopher R., et al.
Publicado: (2020)

The AhR agonist VAF347 augments retinoic acid-induced differentiation in leukemia cells
por: Ibabao, Christopher N., et al.
Publicado: (2015)

Coactivator Recruitment of AhR/ARNT1
por: Endler, Alexander, et al.
Publicado: (2014)

AhR signaling pathways and regulatory functions
por: Larigot, Lucie, et al.
Publicado: (2018)

Epigenetic Regulations of AhR in the Aspect of Immunomodulation
por: Wajda, Anna, et al.
Publicado: (2020)

AhR promotes phosphorylation of ARNT isoform 1 in human T cell malignancies as a switch for optimal AhR activity
por: Bourner, Luke A., et al.
Publicado: (2022)

Editorial: From microbial immunology to microbial therapeutics via targeted delivery technology
por: Puccetti, Matteo, et al.
Publicado: (2022)

AhR and IDO1 in pathogenesis of Covid-19 and the “Systemic AhR Activation Syndrome:” a translational review and therapeutic perspectives
por: Turski, Waldemar A., et al.
Publicado: (2020)

Ethyl Caffeate Can Inhibit Aryl Hydrocarbon Receptor (AhR) Signaling and AhR-Mediated Potentiation of Mast Cell Activation
por: Nguyen, Phuc-Tan, et al.
Publicado: (2023)

Role of AhR/ARNT system in skin homeostasis
por: Furue, Masutaka, et al.
Publicado: (2014)

Bidirectional talk between AhR and Oct4
por: Kang, Bo, et al.
Publicado: (2015)

Induction of AhR-Mediated Gene Transcription by Coffee
por: Ishikawa, Toshio, et al.
Publicado: (2014)

New Treatments in Renal Cancer: The AhR Ligands
por: Itkin, Boris, et al.
Publicado: (2020)

Herbal Plants: The Role of AhR in Mediating Immunomodulation
por: Bungsu, Izzah, et al.
Publicado: (2021)

Defective Glyoxalase 1 Contributes to Pathogenic Inflammation in Cystic Fibrosis
por: Pariano, Marilena, et al.
Publicado: (2021)

Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite
por: Renga, Giorgia, et al.
Publicado: (2022)

Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis
por: D’Onofrio, Fiorella, et al.
Publicado: (2021)

Role of the Arylhydrocarbon Receptor (AhR) in the Pathology of Asthma and COPD
por: Chiba, Takahito, et al.
Publicado: (2012)

Isopsoralen Enhanced Osteogenesis by Targeting AhR/ERα
por: Ge, Luna, et al.
Publicado: (2018)

AhR-deficiency as a cause of demyelinating disease and inflammation
por: Juricek, Ludmila, et al.
Publicado: (2017)

The Role of Aryl Hydrocarbon Receptor (AhR) in Brain Tumors
por: Perepechaeva, Maria L., et al.
Publicado: (2020)

AhR and Cancer: From Gene Profiling to Targeted Therapy
por: Paris, Anaïs, et al.
Publicado: (2021)

The Role of AhR in the Hallmarks of Brain Aging: Friend and Foe
por: Ojo, Emmanuel S., et al.
Publicado: (2021)

Molecular Docking of Natural Compounds for Potential Inhibition of AhR
por: Giordano, Deborah, et al.
Publicado: (2023)

AhR and Wnt/β-Catenin Signaling Pathways and Their Interplay
por: Grishanova, Alevtina Y., et al.
Publicado: (2023)

Towards Targeting the Aryl Hydrocarbon Receptor in Cystic Fibrosis
por: Puccetti, Matteo, et al.
Publicado: (2018)

Red Clover Aryl Hydrocarbon Receptor (AhR) and Estrogen Receptor (ER) Agonists Enhance Genotoxic Estrogen Metabolism
por: Dunlap, Tareisha L., et al.
Publicado: (2017)

Postbiotic-Enabled Targeting of the Host-Microbiota-Pathogen Interface: Hints of Antibiotic Decline?
por: Puccetti, Matteo, et al.
Publicado: (2020)

Tackling Immune Pathogenesis of COVID-19 through Molecular Pharmaceutics
por: Puccetti, Matteo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uvoojmknm5v31p1e3phe6mkd0t